$BSX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$BSX Up to date company activities and other important information about $BSX

$BSX

DD Notes ~ http://www.ddnotesmaker.com/BSX

##### recent news/filings ~ source: finance.yahoo.com

Fri, 23 May 2014 22:30:09 GMT ~ Why Bayer Sold This Division to Boston Scientific
read full: http://www.fool.com/investing/general/2014/05...lnk0000001
*********************************************************

Thu, 22 May 2014 18:22:02 GMT ~ Good News at Boston Scientific: What's Next
read full: http://www.fool.com/investing/general/2014/05...lnk0000001
*********************************************************

Wed, 21 May 2014 15:24:37 GMT ~ Boston Scientific management to meet with Piper Jaffray
read full: http://www.theflyonthewall.com/permalinks/ent...er-Jaffray
*********************************************************

Wed, 21 May 2014 13:14:00 GMT ~ Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months
- PARIS, May 21, 2014 /PRNewswire/ -- Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corporation (BSX) Lotus™ Valve System continued to demonstrate impressive performance at six months, according to new data presented at EuroPCR 2014 in Paris. Results from the REPRISE II clinical trial demonstrated that the Lotus Valve System delivered sustained safety and effectiveness outcomes out to six months, with only 1.1 percent of patients having moderate paravalvular aortic regurgitation (leaking). No severe cases occurred. The data were presented by Professor Ian Meredith, director of MonashHeart, at Monash Medical Centre in Melbourne, Australia, and principal investigator of the REPRISE II trial. The study is evaluating the Lotus Valve System in symptomatic patients with severe aortic valve stenosis considered at high risk for surgical valve replacement. The primary device performance endpoint of 30-day mean aortic valve pressure gradient, as assessed by an independent core lab, was met as the 30-day mean aortic valve pressure gradient of 11.5 +/- 5.2mmHg was significantly less than the performance goal of 18 mmHg (P<0.001). At six months, the mean aortic valve pressure gradient remained low and stable at 11.4 +/- 4.6 mmHg.
read full: http://finance.yahoo.com/news/boston-scientif...00635.html
*********************************************************

Wed, 21 May 2014 12:05:34 GMT ~ Boston Scientific's Synergy stent system reports strong performance data
read full: http://www.theflyonthewall.com/permalinks/ent...mance-data
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=BSX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=BSX&a...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/BSX/company-info
Ticker: $BSX
OTC Market Place: Not Available
CIK code: 0000885725
Company name: Boston Scientific Corp.
Company website: http://www.bsci.com
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/BSX/filings
Latest financials: http://www.otcmarkets.com/stock/BSX/financials
Latest news: http://www.otcmarkets.com/stock/BSX/news - http://finance.yahoo.com/q/h?s=BSX+Headlines

Major holdings: http://data.cnbc.com/quotes/BSX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=BSX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/BSX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=BSX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Boston+Scientific+...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...tific+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.bsci.com
Alexa: http://www.alexa.com/siteinfo/http://www.bsci.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.bsci.com

Short Sales: http://www.otcmarkets.com/stock/BSX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/BSX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/BSX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=BSX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=BSX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=BSX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=BSX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=BSX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=BSX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=BSX
Balance Sheet: http://finance.yahoo.com/q/bs?s=BSX
Cash Flow: http://finance.yahoo.com/q/cf?s=BSX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/BSX
Bloomberg: http://www.bloomberg.com/quote/BSX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=BSX
Bussinessweek: http://investing.businessweek.com/research/st...ticker=BSX
Barchart: http://www.barchart.com/quotes/stocks/BSX
OTC Short Report: http://otcshortreport.com/index.php?index=BSX
Investopedia: http://www.investopedia.com/markets/stocks/BSX/?wa=0

http://www.pennystocktweets.com/stocks/profile/BSX

##### last known share structure ~ source: otcmarkets.com

Market Value: $17,181,556,473 a/o May 29, 2014
Shares Outstanding: 1,322,675,633 a/o Apr 30, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/BSX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 7

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 46

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 8

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Costa Rican Firms Chase Growth at SIAL Paris 2026

Updated Category News Views 4

Chasing Growth in Paris: Costa Rica's Bold Move When it comes to playing the global field, Costa Rica isn't just sitting back; they're on the move. Picture this: PROCOMER, along with 18 standout companies, landed smack dab in the grand hustle and bustle of SIAL Paris 2026. This isn't some leisurely stroll—it's a calculated sprint toward expanding their reach across...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 3

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 50

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 3

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Tenant Improvement: Key to Adapting Lease Spaces

Updated Category News Views 0

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 35

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 46

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

AAR Continues Strong Partnership With Collins Aerospace Products

Updated Category News Views 191

AAR Strengthens Ties with Collins Aerospace AAR CORP. (NYSE: AIR) has recently announced an extension of its exclusive global distribution agreement with Collins Aerospace, a division of RTX. This multi-year partnership focuses on the Goodrich de-icing and specialty systems product line. The agreement emphasizes AAR's commitment to supporting the needs of commercial and...

Continue Reading
Kontoor Brands Shares Exciting Third Quarter Earnings Update

Updated Category News Views 65

Kontoor Brands Announces Third Quarter Earnings Plans Kontoor Brands, Inc. (NYSE: KTB), a prominent player in the global lifestyle apparel sector, is gearing up for an important financial disclosure. The company, known for its highly-regarded Wrangler and Lee brands, has declared its intention to unveil third quarter earnings on a specified date. This announcement is set...

Continue Reading
Wendy's Stock Faces Market Challenges Yet Eyes Recovery

Updated Category News Views 833

Wendy's Stock Faces Market Challenges Yet Eyes Recovery The Wendy's Co (NASDAQ: WEN) has recently faced significant challenges in the stock market, hitting a 52-week low of $14.72. Known for its distinctive square burgers and delicious frosty desserts, Wendy's stock has struggled, reflecting broader market difficulties that are influencing investor sentiments. With a...

Continue Reading
Evoke Pharma Set to Announce Key Financial Results Soon

Updated Category News Views 104

Evoke Pharma Anticipates Financial Announcement Evoke Pharma, Inc. (NASDAQ: EVOK) is ushering in an important moment as it prepares to report its financial results for the fourth quarter and the entire year of 2024. This update is slated for release on a Thursday afternoon, following the closing of the markets. Such earnings reports are crucial for stakeholders keen on...

Continue Reading
JD.com Reports Impressive Q3 2024 Financial Performance

Updated Category News Views 408

A Closer Look at JD.com’s Q3 2024 Results JD.com, Inc. (NASDAQ: JD), a prominent technology and service provider in supply chain management, has recently revealed its financial outcomes for the third quarter of 2024. The company's results reflect its strategic advancements and robust operational performance amid the evolving e-commerce landscape. Financial Highlights In...

Continue Reading